BioCentury | Jul 22, 2020
Emerging Company Profile

Jnana goes after metabolism-mediating proteins, gains Roche as partner

...Furthermore, SLCs are difficult to isolate from a cell and purify. To overcome these challenges, Jnana Therapeutics Inc....
...and a chronic kidney disease candidate. Kotz declined to provide a clinical timeline. COMPANY PROFILE Jnana Therapeutics Inc....
...Targets SLC6A8 (CRT) - Solute carrier family 6 creatine transporter member 8 Elizabeth S. Eaton, Staff Writer Jnana Therapeutics Inc. solute...
BioCentury | Nov 16, 2019
Company News

Management tracks: Lonza CEO to step down; plus Arrowhead, Insmed, Inozyme, Yukin, Pfenex, EyePoint, Verseau, Abingworth, CBC, Flagship, Diverse, Theragnostics,

...Inc. hired Tim Smith as its first CBO. He was a business development consultant for Jnana Therapeutics Inc....
BioCentury | Oct 4, 2019
Company News

Management tracks: J&J hires Bayer’s Swanson; plus Torque, Dynavax, Pact, Deciphera, NextCure, Retrophin, Verve, Jnana and more

...at Brigham and Women's Hospital and was CSO at Lyndra Therapeutics Inc., which he co-founded. Jnana Therapeutics Inc....
BioCentury | Apr 5, 2019
Company News

Management tracks: Zealand taps Alnylam’s Dulac as CEO, plus ICER, Jnana and more

...CSO. Bradt was CMO at Aegerion Pharmaceuticals Inc., a subsidiary of Novelion Therapeutics Inc. (NASDAQ:NVLN). Jnana Therapeutics Inc....
BioCentury | Feb 1, 2019
Finance

Discovering Dewpoint's protein organizers

...could also play a role in cardiovascular disease and women’s health. Nashat was CEO of Jnana Therapeutics Inc....
BioCentury | Nov 7, 2018
Company News

Management tracks: Five Prime, Alder

...IntegenX Inc. until its acquisition this year by Thermo Fisher Scientific Inc. (NYSE:TMO). Metabolic company Jnana Therapeutics Inc....
BioCentury | Dec 15, 2017
Financial News

Jnana launches with $50M series A

...On Dec. 14, Jnana Therapeutics Inc. (Boston, Mass.) launched with a $50 million series A round from existing...
...Kevin Kinsella, Versant's Carlo Rizzuto, AbbVie's Margarita Chavez and Pfizer's Elaine Jones. Jnana Therapeutics Inc., Boston, Mass. Chris Lieu Jnana Therapeutics Inc....
BioCentury | Dec 14, 2017
Financial News

Jnana launches with $50M series A

...includes Nashat, Avalon's Kevin Kinsella, Versant's Carlo Rizzuto, AbbVie's Margarita Chavez and Pfizer's Elaine Jones. Chris Lieu Jnana Therapeutics Inc....
Items per page:
1 - 8 of 8
BioCentury | Jul 22, 2020
Emerging Company Profile

Jnana goes after metabolism-mediating proteins, gains Roche as partner

...Furthermore, SLCs are difficult to isolate from a cell and purify. To overcome these challenges, Jnana Therapeutics Inc....
...and a chronic kidney disease candidate. Kotz declined to provide a clinical timeline. COMPANY PROFILE Jnana Therapeutics Inc....
...Targets SLC6A8 (CRT) - Solute carrier family 6 creatine transporter member 8 Elizabeth S. Eaton, Staff Writer Jnana Therapeutics Inc. solute...
BioCentury | Nov 16, 2019
Company News

Management tracks: Lonza CEO to step down; plus Arrowhead, Insmed, Inozyme, Yukin, Pfenex, EyePoint, Verseau, Abingworth, CBC, Flagship, Diverse, Theragnostics,

...Inc. hired Tim Smith as its first CBO. He was a business development consultant for Jnana Therapeutics Inc....
BioCentury | Oct 4, 2019
Company News

Management tracks: J&J hires Bayer’s Swanson; plus Torque, Dynavax, Pact, Deciphera, NextCure, Retrophin, Verve, Jnana and more

...at Brigham and Women's Hospital and was CSO at Lyndra Therapeutics Inc., which he co-founded. Jnana Therapeutics Inc....
BioCentury | Apr 5, 2019
Company News

Management tracks: Zealand taps Alnylam’s Dulac as CEO, plus ICER, Jnana and more

...CSO. Bradt was CMO at Aegerion Pharmaceuticals Inc., a subsidiary of Novelion Therapeutics Inc. (NASDAQ:NVLN). Jnana Therapeutics Inc....
BioCentury | Feb 1, 2019
Finance

Discovering Dewpoint's protein organizers

...could also play a role in cardiovascular disease and women’s health. Nashat was CEO of Jnana Therapeutics Inc....
BioCentury | Nov 7, 2018
Company News

Management tracks: Five Prime, Alder

...IntegenX Inc. until its acquisition this year by Thermo Fisher Scientific Inc. (NYSE:TMO). Metabolic company Jnana Therapeutics Inc....
BioCentury | Dec 15, 2017
Financial News

Jnana launches with $50M series A

...On Dec. 14, Jnana Therapeutics Inc. (Boston, Mass.) launched with a $50 million series A round from existing...
...Kevin Kinsella, Versant's Carlo Rizzuto, AbbVie's Margarita Chavez and Pfizer's Elaine Jones. Jnana Therapeutics Inc., Boston, Mass. Chris Lieu Jnana Therapeutics Inc....
BioCentury | Dec 14, 2017
Financial News

Jnana launches with $50M series A

...includes Nashat, Avalon's Kevin Kinsella, Versant's Carlo Rizzuto, AbbVie's Margarita Chavez and Pfizer's Elaine Jones. Chris Lieu Jnana Therapeutics Inc....
Items per page:
1 - 8 of 8